Skip to content
Search

Latest Stories

More than 50,000 pregnant women got first dose of Covid-19 vaccine in England

A total of 51,724 pregnant women in England have received their first dose of Covid-19 vaccine, the data from Public Health England (PHE) revealed, as the agency has encouraged more pregnant women to come forward for the vaccination. 

The data shows that these were all women aged under 50 years of age, who reported that they were pregnant or could be pregnant at the time of receiving the vaccine. Of these, 20,648 women have received their second dose.


On 16 April 2021, the Joint Committee on Vaccination and Immunisation (JCVI) advised that pregnant women should be offered the Covid-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group.

Some pregnant women will have been vaccinated before this date if they are clinically vulnerable or are a healthcare worker, therefore these figures are likely to be much higher.

It is preferable for pregnant women in the UK to be offered the Pfizer-BioNTech or Moderna vaccines where available, as there is more safety data available on these vaccines in pregnancy.

Vaccines Minister Nadhim Zahawi said: "It is brilliant to see so many pregnant women coming forward for their Covid-19 vaccines, ensuring they protect themselves and their baby from this awful virus.

"While uncommon, severe illness from Covid-19 is more likely in later pregnancy and infection increases the risk of a premature birth. The Covid-19 vaccines are one of the best defences against infection, preventing at least 11.7 million infections in England alone. I urge everyone – including pregnant women – to get their vaccines as soon as they can."

The Pfizer-BioNTech and Moderna vaccines are recommended for pregnant women in the UK because these vaccines have been given to over 130,000 pregnant women in the US and the data has not raised any safety concerns.

Women who are planning pregnancy, who are in the immediate postpartum period, or who are breastfeeding can be vaccinated with any vaccine, depending on their age and clinical risk group.

New data from PHE has also showed that the vaccination programme has directly averted over 52,600 hospitalisations (approximately 8,800 admissions in those aged 65 to 74; 20,300 in those aged 75 to 84; and 23,500 in those aged 85 and over).

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less